About

Andrew Daniels is currently the Vice President of Compliance Excellence and Transformation at Astellas, a Japan headquartered multinational pharmaceutical and life sciences company. Andrew started his career at aerospace, defence and security company BAE Systems. Following a period at Deloitte, Andrew joined GlaxoSmithKline as Head of Anti-Bribery and Corruption in 2014 before leaving to join Astellas in 2020.